Bayer says Monsanto India integration to complete in one year
Bayer completed the deal to acquire US-based Monsanto recently and the acquisition of Monsanto has been completed globally but it…
Author
Cipla receives final approval for generic version of Impax Laboratories, Albenza
It is an anthelmintic drug indicated for use in treatment of parenchymal neurocysticercosis
Biocon and Mylan announce positive CHMP opinion for Fulphila, Biosimilar Pegfilgrastim
Fulphila was approved by the US FDA earlier this year and is the first FDA-approved biosimilar for Neulasta in the US
Centaur Pharma concludes 10th common cold awareness week campaign
Centaur has been undertaking the 'Common Cold Awareness Week' campaign to prevent people from self medication and encourage them…
Sun Pharma gets Australia TGA nod for plaque psoriasis treatment drug
Sun Pharma is to launch a patient support programme to assist patients prescribed with this drug
Schott Kaisha hosts pharma packaging stalwarts at its Jambusar plant, Gujarat
More than 60 delegates took part in the half-day visit to Schott Kaisha’s state-of-the-art facility
GSK grabs new drug development head from Boehringer
GlaxoSmithKline has hired Chris Corsico from German drugmaker Boehringer Ingelheim
AstraZeneca plots China robot offensive to counter price cuts
With smart cancer diagnostics and AI systems to improve ambulance pick-ups for patients with chest pain, AstraZeneca aims to move…
Alembic Pharma gets USFDA nod for depressive disorder drug
The company has received approval from the USFDA to market its product which is a generic equivalent of Wyeth Pharma Inc's Pristiq…
Aurobindo Pharma gets nod from South African health authority for HIV drug
The approval further strengthens the company's HIV product basket in South Africa, which has the potential to improve the lives of…